Amphastar Delivers Strong Quarter With Epinephrine Gains

As Company’s US Glucagon Rival Performs Well

 
• By Akriti Seth
  
Gain
Company sees 34% increase in Primatene Mist (epinephrine) sales in Q2 FY21 • Source: Alamy

More from Biosimilars

More from Products